These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 30561809)

  • 41. Pluripotent-derived Mesenchymal Stem/stromal Cells: an Overview of the Derivation Protocol Efficacies and the Differences Among the Derived Cells.
    de Matos BM; Robert AW; Stimamiglio MA; Correa A
    Stem Cell Rev Rep; 2022 Jan; 18(1):94-125. PubMed ID: 34545529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of IKK/NF-κB Signaling Enhances Differentiation of Mesenchymal Stromal Cells from Human Embryonic Stem Cells.
    Deng P; Zhou C; Alvarez R; Hong C; Wang CY
    Stem Cell Reports; 2016 Apr; 6(4):456-465. PubMed ID: 26972683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma.
    Potter DR; Miyazawa BY; Gibb SL; Deng X; Togaratti PP; Croze RH; Srivastava AK; Trivedi A; Matthay M; Holcomb JB; Schreiber MA; Pati S
    J Trauma Acute Care Surg; 2018 Feb; 84(2):245-256. PubMed ID: 29251710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model.
    Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y
    Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An In Vitro Comparative Study of Multisource Derived Human Mesenchymal Stem Cells for Bone Tissue Engineering.
    Zhang Y; Xing Y; Jia L; Ji Y; Zhao B; Wen Y; Xu X
    Stem Cells Dev; 2018 Dec; 27(23):1634-1645. PubMed ID: 30234437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of mesenchymal stem cells derived from human pluripotent stem cells in regenerative medicine.
    Liu TM
    World J Stem Cells; 2021 Dec; 13(12):1826-1844. PubMed ID: 35069985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single cell-derived clonally expanded mesenchymal progenitor cells from somatic cell nuclear transfer-derived pluripotent stem cells ameliorate the endometrial function in the uterus of a murine model with Asherman's syndrome.
    Jun SM; Park M; Lee JY; Jung S; Lee JE; Shim SH; Song H; Lee DR
    Cell Prolif; 2019 May; 52(3):e12597. PubMed ID: 30896075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In utero transplantation of human bone marrow-derived multipotent mesenchymal stem cells in mice.
    Chou SH; Kuo TK; Liu M; Lee OK
    J Orthop Res; 2006 Mar; 24(3):301-12. PubMed ID: 16482576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical applications and biosafety of human adult mesenchymal stem cells.
    Mariani E; Facchini A
    Curr Pharm Des; 2012; 18(13):1821-45. PubMed ID: 22352750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives.
    Liang X; Ding Y; Zhang Y; Tse HF; Lian Q
    Cell Transplant; 2014; 23(9):1045-59. PubMed ID: 23676629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone marrow mesenchymal stem cells.
    Ohishi M; Schipani E
    J Cell Biochem; 2010 Feb; 109(2):277-82. PubMed ID: 19950205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myogenic properties of human mesenchymal stem cells derived from three different sources.
    de la Garza-Rodea AS; van der Velde-van Dijke I; Boersma H; Gonçalves MA; van Bekkum DW; de Vries AA; Knaän-Shanzer S
    Cell Transplant; 2012; 21(1):153-73. PubMed ID: 21669036
    [TBL] [Abstract][Full Text] [Related]  

  • 53. hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine.
    Sabapathy V; Kumar S
    J Cell Mol Med; 2016 Aug; 20(8):1571-88. PubMed ID: 27097531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mesenchymal Stem/Stromal Cell-Based Therapy for Heart Failure　- What Is the Best Source?
    Kobayashi K; Suzuki K
    Circ J; 2018 Aug; 82(9):2222-2232. PubMed ID: 30089767
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isolation and differentiation of human mesenchymal stem cells obtained from second trimester amniotic fluid; experiments at Chang Gung Memorial Hospital.
    Peng HH; Wang TH; Chao AS; Chang SD
    Chang Gung Med J; 2007; 30(5):402-7. PubMed ID: 18062170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concise Review: Rational Use of Mesenchymal Stem Cells in the Treatment of Ischemic Heart Disease.
    Ward MR; Abadeh A; Connelly KA
    Stem Cells Transl Med; 2018 Jul; 7(7):543-550. PubMed ID: 29665255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GMP-compatible and xeno-free cultivation of mesenchymal progenitors derived from human-induced pluripotent stem cells.
    McGrath M; Tam E; Sladkova M; AlManaie A; Zimmer M; de Peppo GM
    Stem Cell Res Ther; 2019 Jan; 10(1):11. PubMed ID: 30635059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunological properties of mesenchymal stem cells and clinical implications.
    Patel SA; Sherman L; Munoz J; Rameshwar P
    Arch Immunol Ther Exp (Warsz); 2008; 56(1):1-8. PubMed ID: 18250975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Translating mesenchymal stem cell and their exosome research into GMP compliant advanced therapy products: Promises, problems and prospects.
    Ma CY; Zhai Y; Li CT; Liu J; Xu X; Chen H; Tse HF; Lian Q
    Med Res Rev; 2024 May; 44(3):919-938. PubMed ID: 38095832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current thoughts on the therapeutic potential of stem cell.
    Rameshwar P
    Methods Mol Biol; 2012; 879():3-26. PubMed ID: 22610550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.